Nu Skin Enterprises (NYSE:NUS) Updates Q1 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.100-0.200 for the period, compared to the consensus earnings per share estimate of 0.160. The company issued revenue guidance of $345.0 million-$365.0 million, compared to the consensus revenue estimate of $404.6 million. Nu Skin Enterprises also updated its FY 2025 guidance to 0.900-1.300 EPS.

Nu Skin Enterprises Trading Up 1.3 %

NUS stock traded up $0.09 during midday trading on Thursday, reaching $6.41. 1,299,428 shares of the company’s stock traded hands, compared to its average volume of 687,522. The business has a 50-day moving average price of $6.91 and a two-hundred day moving average price of $7.50. Nu Skin Enterprises has a fifty-two week low of $5.95 and a fifty-two week high of $17.68. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20. The company has a market capitalization of $318.40 million, a P/E ratio of -3.09 and a beta of 1.17.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. Equities research analysts forecast that Nu Skin Enterprises will post 0.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on NUS shares. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th. DA Davidson reduced their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. Finally, Citigroup reduced their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.